Blood cancers- we’re making a difference
Every day, 70 people in the UK are told they have a blood cancer. We’re working to change this. Right now we have 22 active research projects all making progress against blood cancers. You can search our database for current projects against blood cancers here.
Blood cancers are a group of conditions including leukaemia, lymphoma, and myeloma. All of these cancers can disrupt the immune system, making even very mild infections dangerous to the patient.
Acute myeloid leukaemia (AML) affects 2,600 adults a year in the UK and is most common in older people. Dr Brian Huntly at the University of Cambridge, UK, is trying to find new ways to treat AML. He is studying how three specific proteins may interact to drive the condition.
“If this research is successful,” says Dr Huntly, “it will set the scene for targeting the interactions between these three proteins as a much needed potential novel therapeutic for AML.”
Working in the Netherlands, Dr Tuna Mutis is driving forward development of a potential new way to stop myeloma, a cancer of the plasma cells, becoming resistant to treatment. His lab has recently made progress in understanding why multiple myeloma cells can sometimes become resistant to immunotherapy, and he is now using our funding to build on these findings.
And we’ve already told you about Professor Christian Münz in Switzerland and his pioneering work developing a vaccine against a lymphoma-causing virus.
It’s only thanks to our supporters that we can fund valuable blood cancer research like this- and it’s already having an impact. See here how our research is making a difference to patients with the rare genetic blood disease Fanconi anaemia.
Find out more about signs and symptoms of blood cancers here.